Dr. Josh Hill commented on a study of Remdesivir in high-risk patients:
Dr. Trevor Bedford predicted near-term and future spread of SARS-CoV-2.
Dr. Julie McElrath noted that COVID vaccines continue to prevent hospitalization and death.
Dr. Julie McElrath and collaborators from the Allen Institute discussed research in immune response and understanding long COVID.
Dr. Larry Corey noted that vaccine boosters may prevent transmission.
Dr. Trevor Bedford characterized the landscape of COVID variants.
Dr. Trevor Bedford commented on the volume of COVID genomes now available in the U.S.
Dr. Larry Corey characterized results from an HIV vaccine study he helped lead.
Dr. Steve Pergam and Elizabeth Krantz discussed their study on cancer patients and immunity to measles and mumps.
Dr. Holly Janes spoke with NPR.
Dr. Larry Corey discussed COVID vaccine boosters.
Dr. Larry Corey discussed breakthrough cases of COVID.
Dr. Josh Schiffer discussed the rise of variants.
Dr. Steve Pergam and Elizabeth Krantz discussed their study on measles and mumps immunity in cancer patients.
Dr. Steven Pergam and biostatistician Elizabeth Krantz discussed their research on cancer patients and immunity to mumps and measles.
Dr. Peter Gilbert explained a new study identifying correlates of protection for the Moderna vaccine.
Dr. Peter Gilbert explained a study identifying correlates of protection for the Moderna virus.
Dr. Peter Gilbert explained a study identifying correlates of protection for the Moderna virus.
Dr. Larry Corey commented on COVID vaccines in immunocompromised people.
Dr. Trevor Bedford commented on the delta variant with The Washington Post.
Dr. Rachel Bender Ignacio explained how small molecule antivirals still work when viruses develop resistance.
Dr. Larry Corey expressed concern about using partial doses of COVID vaccines to increase global access to the vaccines without clinical data.
Dr. Trevor Bedford described the newly emerged Lambda variant.
Dr. Trevor Bedford commented on the rise in circulating respiratory viruses as COVID restrictions decrease.
Dr. Peter Gilbert told KIRO 7 about how he is working to find the “correlate of protection."
Dr. Michele Andrasik commented on building vaccine confidence.
Dr. Josh Hill emphasized how broad COVID vaccination can “protect our vulnerable patient populations within the community who either can’t get vaccinated for some reason, or who may not have as good of a vaccine response.”
Dr. Josh Schiffer stressed rapid vaccination.
Dr. Jim Kublin spoke with CNN about next-gen vaccine delivery technologies.
Dr. Holly Janes explained the PreventCOVIDU study of COVID vaccines and transmission.
Drs. Tony Fauci and Larry Corey reflected on their collaboration on HIV and COVID vaccines.
Dr. Peter Gilbert discussed studies of what immune responses protect against COVID-19.
Dr. Peter Gilbert discussed how to test vaccine protection against SARS-CoV-2 variants.
Dr. Larry Corey commented on the challenge of creating an effective HIV vaccine.
Dr. Stephaun Wallace reflected on his career in public health.
Dr. Larry Corey explained one of the questions the Prevent COVID U study is designed to answer:
Dr. Josh Schiffer spoke with Geekwire and gave his input on SARS-CoV-2 variants.
Bill Gates featured Dr. Stephaun Wallace’s work in his personal blog.
In a Q&A, Dr. Steve Pergam discussed national guidelines on COVID vaccines in cancer patients.
Dr. Josh Schiffer explained his team’s latest analysis of how super-spreader events allow variants to become predominant and create new variants.
Dr. Trevor Bedford commented on advances in the viral genomics field.
Dr. Larry Corey characterized results from the Antibody Mediated Prevention studies, coordinated through the HIV Vaccine Trials Network, as “important proof of concept” in using antibody infusions to prevent HIV.
Dr. Steve Pergam reflected on how public health measures helped reduce spread of other respiratory viruses.
STAT opinion included reflections on the pandemic from a variety of experts when they realized COVID-19 was here to stay.
Dr. Trevor Bedford commented on which variants we should watch and how concerned people should be..
Dr. Josh Schiffer provided context on how the new coronavirus variants makes modeling difficult.
Dr. Josh Hill cautioned that high school sports may be disrupted by COVID-19.
Dr. Andy McGuire discussed findings from the Seattle COVID Cohort Study showing a “massive, massive boost” from the vaccine administered to people who had had COVID.
Drs. Steve Pergam and Michele Andrasik stressed the need for more diversity and inclusion in vaccine clinical trials.
Dr. Trevor Bedford commented on new funding to support genomic surveillance and data collection related to COVID.
Dr. Peter Gilbert described measuring immune responses to vaccines as a way of testing their efficacy.
Dr. Larry Corey gave his thoughts to Business Insider about SARS-CoV-2 becoming endemic.
In an op-ed, Dr. Josh Schiffer advocated for increased masking to limit the COVID-19 pandemic.
Dr. Larry Corey gave his insight on the pause in rolling out the AstraZeneca vaccine in South Africa.
Dr. Steve Pergam explained why people should get their COVID-19 vaccines from the same provider.
Dr. Larry Corey was quoted in The Washington Post on the potential for reinfection from some variants.
Dr. Catherine Liu commented on emerging recommendations for cancer patients receiving COVID-19 vaccines.
Dr. Larry Corey reflected on results from the Antibody Mediated Prevention study.
Dr. Trevor Bedford weighed in on modeling that predicted lifting public health guidelines in February could cause 29 million additional coronavirus cases by July.
Dr. Larry Corey stressed that to slow the spread of variants of concern, as we expand access to COVID-19 vaccines, “We have to do everything we can to decrease the risk of transmission and acquisition.”
Drs. Pavitra Roychoudhury, Jesse Bloom and Trevor Bedford commented on efforts to track SARS-CoV-2 variants.
Dr. Trevor Bedford estimated that with a more transmissible variant, “It makes the same situations that generate spread now — people living in the same household, these sorts of non-ventilated indoor contacts — to be more likely to spread.”
Dr. Fabian Cardozo-Ojeda described the collaboration that went into utilizing models to potentially cure HIV through stem cell transplants.
Research nurse Corrie Moreau described her motivation for being involved with COVID-19 therapy studies.
Dr. Jesse Bloom cautioned not to overly concerned about a new coronavirus strain and how dangerous it could be.
Dr. Steve Pergam shared the importance of COVID-19 prevention measures for cancer patients.
Dr. Josh Schffer emphasized why it’s important to understand if COVID-19 vaccines prevent asymptomatic infections and transmissions.
Drs. Jesse Bloom and Trevor Bedford discussed implications of SARS-CoV-2 mutating.
Dr. Larry Corey commented on the diverse populations that were enrolled in the Moderna vaccine study.
Dr. Jim Kublin reflected on progress in developing COVID-19 vaccines:
Drs. Michele Andrasik and Adrienne Shapiro emphasized the disproportionate impact of COVID-19 on communities of color.
Dr. Larry Corey underscored the benefit of COVID vaccines.
Dr. Josh Hill shared guidance for cancer patients and the COVID-19 vaccine.
The New Yorker gave updates on vaccine trials and the first vaccines to get emergency approval.
Dr. Josh Hill shared insight into the CDC’s new guidelines around quarantining after exposure to COVID-19.
Dr. Holly Janes discussed biostatistical implications of having placebo-treated volunteers offered the vaccine.
Dr. Larry Corey characterized the latest data on Moderna’s COVID-19 vaccine candidate.
Dr. Larry Corey outlined a new plan to test if COVID-19 vaccines prevent infection.
Dr. Trevor Bedford confirmed his assessment that scientific evidence shows the 614G variant of SARS-CoV-2 is more easily transmitted.
Dr. Josh Schiffer authored an opinion piece urging Americans to take proper COVID-19 measures.
Dr. Trevor Bedford predicted that U.S. COVID-19 deaths could reach 2,000 a day within weeks, and that “Importantly, this doesn’t assume any further increases in circulation and is essentially ‘baked into’ currently reported cases.”
Dr. Larry Corey summarized the role Fred Hutch and the COVID-19 Prevention Network is playing during the pandemic.
Dr. Josh Schiffer detailed why the MLS may face more COVID-19 related cancellations.
Dr. Steve Pergam stressed the need for families to rethink holiday gatherings during the COVID-19 pandemic.
Dr. Larry Corey reflected on the speed of COVID-19 vaccine development.
Dr. Julie McElrath explained that her team is working to enroll people who “are over 65 years old, those who may have some kind of underlying medical conditions such as heart disease, high blood pressure, diabetes” into the Fred Hutch vaccine trial.
Dr. Julie McElrath discussed several COVID vaccines being tested in phase 3 trials in the Seattle area.
Dr. Steve Pergam underscored the importance of taking COVID-19 precautions during the holidays.
Dr. Josh Hill discussed treating immune responses in COVID-19 patients.
Fred Hutchinson Cancer Research Center Research announced Monday that it has opened its COVID-19 Clinical Research Center.
In an op-ed piece, Dr. Josh Schiffer suggested COVID-19 strategies can be flawed but still effective in reducing transmission.
Dr. Alpana Waghmare described why Fred Hutch's CovidWatch study is now available for Spanish-speaking volunteers.
Dr. Trevor Bedford reflected on discovering the first case of community transmission in the region in this comic feature.
Dr. Steve Pergam described how the COVID-19 pandemic could impact other infections.
Dr. Trevor Bedford spoke about the early cases of COVID in the U.S.
Dr. Daniel Reeves described how increased masking is the key to lowering COVID-19 transmissions.
Dr. Larry Corey discussed the importance of conducting vaccine trials to the highest scientific standards.
Dr. Larry Corey discussed the purpose of CoVPN’s national ad campaign.
In an FAQ about vaccine trial statistics, Holly Janes explained how the COVID-19 trials are based on how many cases of the disease.
Dr. Jim Kublin discussed the need for volunteers in the COVID-19 clinical trial registry.
Dr. Trevor Bedford was selected for Fortune’s 40 under 40 in the healthcare category.
Dr. Dobromir Dimitrov provided outside commentary on a new model focused on safely reopening schools.
Dr. Josh Schiffer provided outside commentary on a new study looking at a COVID-19 superspreading event in Boston.
Dr. Keith Jerome discussed his new study showing how gene editing removed 90% of herpes in mice.
Peter Gilbert discussed vaccine clinical trial design in a story about national efforts to rapidly find a safe and effective vaccine.
Dr. Josh Schiffer described the role T-cells play in COVID-19 immune responses.
Dr. Larry Corey commented on how discussions are underway to include pregnant women and children in COVID-19 vaccine trials.
Fred Hutch scientists described their new analysis on safely reopening schools.
Dr. Elizabeth Halloran discussed the design of vaccine clinical trials and shared information on how people can register as a volunteer..
Dr. Steve Pergam raised concerns about how unnecessary COVID-19 testing could lead to negative behaviors.
Dr. Julie McElrath discussed the benefits of working with the Allen Institute for COVID-19 research.
Dr. Julie McElrath’s work with the Allen Institute to understand the characteristics of an effective COVID-19 immune response was covered by GeekWire.
Dr. Josh Schiffer described how to prevent COVID-19 superspreader events
Dr. Josh Schiffer shot down the idea of achieving natural herd immunity for COVID-19.
Dr. Steve Pergam raised concerns over MLS matches resuming.
Dr. Josh Schiffer emphasized the importance of “superspreader” events and COVID-19.
Kaiser Health News explored issues of vaccine efficacy in obese individuals, quoting Dr. Larry Corey.
Dr. Steve Pergam described the importance of getting flu shots, especially for protecting babies, older people and others with compromised immune systems.
Dr. Steve Pergam expressed concerns over COVID-19 testing and the impact on underrepresented populations.
Dr. Jim Kublin answered questions about the CoVPN program, the challenges of the program and more.
Dr. Larry Corey explained CoVPN’s focus on including people at most risk for COVID-19 in the vaccine trials, specifically minorities and people with comorbidities.
Michele Andrasik spoke about the priorities of CoVPN and the COVID-19 vaccine trials.
Stephaun Wallace spoke about the barriers to clinical trial enrollment in Black, Latino and other minority populations, and the strategies to encourage those populations to participate in clinical trials.
Dr. Larry Corey discussed CoVPN trial enrollment goals in terms of reaching a diverse, multigenerational population.
Michele Andrasik discussed how outreach methods may need to differ depending on the communities that researchers are trying to reach with COVID-19 trials.
Dr. Joshua Schiffer predicted what may happen if the U.S. tries to achieve herd immunity without a COVID-19 vaccine.
Dr. Jim Kublin discussed the CoVPN program, trial recruitment and vaccine development.
Dr. Steve Pergam weighed in on what we can do now to slow COVID-19, emphasizing physical distancing measures, PPE, test and tracing plans and masking.
Trevor Bedford’s work and comments on COVID-19 from the beginning of the pandemic are referenced.
Stephaun Wallace discussed the details of the CoVPN clinical trials and the focuses of the program.
Trevor Bedford discussed his work with Nextstrain and the start of tracking COVID-19 in Seattle.
Keith Jerome’s antibody work and antibody study results from the Fred Hutch campus are discussed.
Dr. Larry Corey’s comments saying a vaccine that is safe and works in at least 50% of people would be viable are discussed.
Forbes covered the CoVPN program, its goals and how the network will be run.
Stephaun Wallace provided information about the CoVPN network, specifically the call for diverse applicants across ethnic, racial, occupational groups and ages.
Dr. Jim Kublin explained the CoVPN network, and the goals of the program.
Dr. Steve Pergam shares tips to reduce the infection risk of COVID-19.
Dr. Larry Corey is mentioned for comments on the CoVPN registry, and the call for diverse trial participants.
Comedian Joel McHale spoke about his conversations on COVID-19 with Dr. Joshua Schiffer.
Dr. Larry Corey discussed how building the HIV trial network laid the foundation for CoVPN.
Research from Fred Hutch indicating the COVID-19 infection rate in Washington is increasing above peak levels from March is referenced.
Dr. Joshua Schiffer commented on the trend of younger people getting COVID-19 and their risks.
The CoVPN announcement is covered by KING 5.
Julie Czartoski explained the goals of the COVID cohort study and the value of enrolling first responders like firefighters.
Julie Czartoski discussed testing the Everett’ Fire Station as part of the COVID cohort study.
Dr. Jim Kublin commented on the timeline and goals of the CoVPN network.
Trevor Bedford discussed his work on SARS-CoV-2 genomic epidemiology using twitter for science outreach and communications.
Dr. Larry Corey discussed the CoVPN network, how the vaccine trials will be run and his role in the program.
Dr. Larry Corey discussed how the CoVPN trial network will work and the goals of the program.
Forbes covered the CoVPN announcement and Fred Hutch’s role in the network of clinical trials.
Dr. Larry Corey commented on the role Fred Hutch will take in developing coronavirus vaccines, building off of work with HIV vaccines.
CNN covered the announcement of the CoVPN network, of which Fred Hutch will serve as the coordination center and Dr. Larry Corey as the lead.
Dr. Steve Pergam commented on the restarting of professional sports in July, reinforcing that it may be necessary to stop if COVID-19 cases rise.
Trevor Bedford weighed in on new findings suggesting COVID-19 was spreading in New York City in early February.
Trevor Bedford explained how Nextstrain and genomic epidemiology can inform public health and discussed the COVID-19 pandemic.
Dr. Keith Jerome and Trevor Bedford explained the rise in positive COVID-19 tests, indicating a rise in infections rather than false positives.
Dr. Julie McElrath discussed the COVID Cohort study to gather information on first responders and those who are likely to be exposed to the virus.
Dr. Catherine Liu commented on COVID-19 and cancer patients, and the risk for more severe infection.
Elizabeth Halloran commented on the lack of clarity in COVID-19 infection case counts, suggesting the total number is much higher than current estimates.
Dr. Larry Corey explained ‘Operation Warp Speed’ for developing COVID-19 vaccines, and the safety and efficacy standards of the program.
The New York Times recapped the COVID-19 pandemic, referencing Trevor Bedford’s work tracking the virus through Nextstrain and the Seattle Flu Study.
Dr. Steve Pergam weighed in on the potential impact of reopening restaurants, loosening other restrictions, and protests on COVID-19 infection rates.
Dr. Joshua Schiffer’s new review paper, with co-authors from Fred Hutch and UW, suggesting that an early test and treat strategy is the best way to control COVID-19, is covered.
A review article by Dr. Joshua Schiffer on ways to keep COVID-19 from getting out of control again is covered, highlighting the need for widespread testing and treatment early in diagnosis.
Dr. Joshua Schiffer’s new article emphasizing the need for widespread testing and early treatment for COVID-19 is discussed.
Data on COVID-19 infection rates from Fred Hutch, suggesting the infection rate in Washington State has risen, is referenced.
Dr. Steve Pergam weighed in on the risks of starting up the NBA season during COVID-19.
Dr. Joe Unger’s research with the SWOG network suggesting health insurance plays a role in clinical trial success for patients is discussed.
Dr. Larry Corey discussed COVID-19 vaccine trials and the challenges involved.
Yuan Tian explained how inflammation factors into COVID-19, and the need for further studies on immune cells.
Dr. Larry Corey explained the complexities of COVID-19 vaccine trial setup and development.
Fred Hutch is mentioned for involvement in an HIV and COVID-19 study team, to determine if patients with HIV are at higher risk of more severe infection.
Dr. Larry Corey discussed COVID-19 vaccine trials, the timelines, and how they will be structured.
Trevor Bedford’s tweets on COVID-19 and protesting are referenced.
Trevor Bedford’s estimates of COVID-19 infections resulting from protests are referenced.
Trevor Bedford’s tweets on estimates of COVID-19 infection rates after protests in the U.S. are referenced.
Dr. Larry Corey and Dr. John Mascola’s webinar on COVID-19 vaccine development is quoted, specifically that vaccine development will require coordination from all industries.
A Fred Hutch webinar featuring Dr. Larry Corey and Dr. John Mascola of NIAID on COVID-19 vaccine development is recapped by GeekWire.
Laura Matarajt explained how and why physical distancing works to help prevent the spread of COVID-19.
Medium referenced the CovidWatch program as part of Amazon’s role in COVID-19 response.
Yuan Tian discussed the value that further research on T-cell responses in people with severe and mild COVID-19 infection could provide, in light of an outside study showing immune response in those without exposure.
Dr. Joshua Schiffer weighed in on the safety of travel during the COVID-19 pandemic, and possible ways to keep infection risk low.
Trevor Bedford discussed his COVID-19 research, the test, trace, isolate strategy and next steps to reopen.
Jesse Bloom and colleagues explained results of a recent study showing 1% of children tested had COVID-19 antibodies, about at the same rate as adults.
Trevor Bedford commented on the possibility of COVID-19 infection in early January, suggesting it was likely flu.
Trevor Bedford is quoted on an updated analysis suggesting the WA1 COVID-19 patient was not the initial start to the outbreak in Washington.
Allison Black explained COVID-19 contact tracing apps, and how they can be leveraged to slow COVID-19 spread.
Louise Moncla discussed new research suggesting a second introduction of COVID-19 led to the outbreak in Washington.
Trevor Bedford discussed his updated analysis suggesting the COVID-19 outbreak began in Seattle in February.
Trevor Bedford’s analysis of COVID-19 genomes suggesting Washington’s outbreak came from an alternative source than the original patient is referenced.
Trevor Bedford’s tweets on the start of the COVID-19 outbreak in Washington and patient WA1 are discussed.
Dr. Larry Corey is quoted on COVID-19 vaccine development progress.
Louise Moncla commented on mutations in SARS-CoV-2 and the lack of knowledge around the impact they have on the virus.
President Dr. Thomas Lynch discussed Fred Hutch’s work related to COVID-19 virology, epidemiology and vaccine programs.
Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19.
Dr. Larry Corey suggested potential timeframes for the development of a COVID-19 vaccine.
Dr. Larry Corey discussed the current status of COVID-19 vaccine trials.
Allison Black weighed in on COVID-19 contact tracing apps and the features they need to be effective.
Dr. Joshua Schiffer weighed in on the possibility of reinfection with COVID-19, saying more research is needed.
Dr. Larry Corey is quoted for the announcement of COVID-19 vaccine trials.
Dr. Elizabeth Halloran explained how we can use COVID-19 models to our advantage, and her recent modeling work and some of the caveats of model predictions.
Trevor Bedford is quoted on the lack of full COVID-19 suppression in the U.S. and the implications on further physical distancing policies.
Trevor Bedford is listed for receiving a Webby Special Achievement award for Nextstrain.
Bloomberg cited the CovidWatch study as one of the ways Amazon is working to stop COVID-19.
Dr. Larry Corey explained COVID-19 vaccine strategy and the current status of research around COVID-19 in this video interview with Science.
Dr. Steve Pergam commented on the shutdown of SCAN by the FDA.
Dr. Keith Jerome discussed COVID-19 virology, the possibility of reinfection, and transmission.
Trevor Bedford’s comments on the COVID-19 status and lack of viral suppression in the U.S. are referenced.
The Covidwatch study is profiled, with Dr. Michael Boeckh explaining the study goals.
Dr. Trevor Bedford weighed in on when COVID-19 arrived in the U.S., the origins of the virus, and more.
Dr. Elizabeth Halloran discussed COVID-19 testing, strategy, and modeling with other biostatisticians and epidemiologists studying the virus.
Dr. Joshua Schiffer commented on the feasibility of staying safe from COVID-19 in large group gatherings such as concerts.
Trevor Bedford’s genomic analysis exploring the spread of COVID-19 across the U.S. is highlighted, along with Nextstrain.
KIRO 7 covered the CovidWatch program, led by Dr. Michael Boeckh, which aims to better understand COVID-19.
The SCAN program is explored, specifically it’s challenges and goals to track COVID-19 spread.
Dr. Larry Corey discussed COVID-19 vaccine development and clinical trials.
The SCAN Initiative and the role of Gates Ventures in the program are discussed.
Dr. Larry Corey commented on COVID-19 vaccine trials and strategy.
Business Insider referenced an editorial piece co-written by Drs. Larry Corey, Anthony Fauci and other experts on COVID-19 vaccine development.
The SCAN initiative is profiled by Gates Notes, mentioning Fred Hutch as a partner.
The SCAN initiative and Gates Notes article on the program are discussed.
Dr. Larry Corey’s co-authored editorial in Science, explaining a roadmap to a COVID-19 vaccine and calling for a variety of approaches and collaboration, is discussed.
The Science piece co-authored by Drs. Larry Corey, Anthony Fauci, Francis Collins and John Mascola is cited.
Dr. Larry Corey is quoted on the need for collaboration and multiple COVID-19 vaccines, in relation to the release of a co-authored piece on COVID-19 vaccine development in Science.
GeekWire highlighted a Bank of America grant that will fund Fred Hutch COVID-19 response and the purchase of medical supplies for SCCA.
GeekWire featured Dr. Larry Corey’s Science perspective, co-authored with Drs Anthony Fauci, John Mascola and Francis Collins, on proposed COVID-19 vaccine plans.
KOMO profiled the COVIDWatch study led by Dr. Michael Boeckh to track COVID-19 in the population.
Trevor Bedford’s discovery of COVID-19 community spread through the Seattle Flu Study is referenced.
Dr. Larry Corey is discussed along with the co-authors Drs. Anthony Fauci, John Mascola and Francis Collins, on a Science perspective piece on the development of a COVID-19 vaccine.
Allison Black is mentioned for a segment where she discussed COVID-19 tracking and her work in the Bedford lab.
Dr. Keith Jerome is quoted on the impact that early physical distancing measures had in lowering COVID-19 rates in Washington.
Bloomberg quoted Trevor Bedford on statements suggesting that further research is needed to determine if one COVID-19 strain is more transmissible than others.
Dr. Elizabeth Halloran explained how easily accessible and repeated testing, contract tracing and isolation when sick could keep COVID-19 under control without a vaccine.
Trevor Bedford weighed in on serology testing, the true COVID-19 incidence in the U.S., and how we could use blood samples to retroactively test for COVID-19.
Dr. Elizabeth Halloran discussed the need for increased COVID-19 testing and contact tracing to justify loosening physical distancing measures
Trevor Bedford’s statements on the implications of a mutation in SARS-Cov-2’s spike proteins are referenced.
STAT covered the new COVIDWatch study and partnership with Amazon, aimed at learning more about COVID-19’s infection rate and if infection confers immunity.
Dr. Josh Schiffer explained the complexity of COVID-19 immune response and variability across patients.
Business Insider discussed Nextstrain work and Trevor Bedford’s comments on COVID-19 lineages and the unknown impact on transmissibility.
Trevor Bedford’s commentary on a COVID-19 spike mutation is referenced, suggesting we don’t know the impact of the mutation on transmissibility.
Trevor Bedford stated that it’s not possible SARS-CoV-2 was circulating in the U.S. in or before November 2019.
Trevor Bedford’s statements on the impacts of a SARS-Cov-2 mutation are cited, saying we need further research to determine if it impacts transmissibility.
Trevor Bedford’s statements predicting continued COVID-19 infections across the U.S. are cited.
Trevor Bedford’s commentary on the lack of accuracy of some COVID-19 antibody tests is included.
Louise Moncla provided insight to why there are likely unknown early February COVID-19 deaths.
Dr. Steve Pergam discussed the importance of early detection of COVID-19 in Washington’s virus response.
Trevor Bedford reinforced the scientific reasons why COVID-19 did not originate from a lab, but rather a natural setting.
Trevor Bedford is listed as a source of COVID-19 spread and tracking data.
Pavitra Roychoudhury discussed her work with COVID-19 genomics and tracking, specifically a sequence sharing project.
Dr. Elizabeth Halloran commented on the potential outcomes of easing physical distancing restrictions too early.
Dr. Elizabeth Duke explained issues trying to find a drug to properly control and treat COVID-19.
Dr. Larry Corey weighed in on the use of HIV ARV’s as potential treatments for COVID-19.
Trevor Bedford’s analysis that COVID-19 was introduced to the US sometime in January is referenced.
GeekWire highlighted Trevor Bedford’s research tracking COVID-19, and referenced a webinar featuring Dr. Elizabeth Halloran.
Russell Campbell commented on how the COVID-19 pandemic echoes the AIDs epidemic in its impact on minorities and under-served populations.
Trevor Bedford’s timeline of the COVID-19 pandemic in the U.S. beginning in early January is referenced.
Dr. Elizabeth Halloran suggested what may happen as a result of relaxing physical distancing measures too early.
Dr. Elizabeth Halloran gave insight to what may happen is physical distancing measures are loosened.
Trevor Bedford is included as a credible source of COVID-19 information.
Trevor Bedford is quoted on his test, trace, isolate strategies to stop the COVID-19 pandemic.
Trevor Bedford’s comments on new antibody study results suggesting high antibody prevalence in the community are included.
Trevor Bedford’s analysis of the death rate from COVID-19 in New York City is referenced.
Trevor Bedford’s and Nextstrain collaborator Emma Hodcraft’s comments on the mutation rate of COVID-19 and the implications of that for vaccine efficacy are discussed.
Dr. Elizabeth Halloran discussed how COVID-19 differs from other infectious diseases like measles, specifically in its higher transmissibility.
Dr. Elizabeth Halloran suggested that while we hope being infected with COVID-19 produces immunity for at least a year, further research is needed to confirm.
Andy McGuire commented on the vaccine development process in reference to COVID-19 vaccine research.
Trevor Bedford’s statements suggesting undetected COVID-19 spread across Washington in late February are cited.
Wired discussed Trevor Bedford’s rise to Twitter fame through his research communications in a larger piece on Twitter as a news source.
The New York Times referenced Trevor Bedford’s genetic analysis work placing the start of the COVID-19 outbreak in Washington in early February, in light of new data on an early February COVID-19 death.
Trevor Bedford’s tweets reinforcing that COVID-19 was not circulating in the U.S. in December are cited.
Dr. Elizabeth Halloran commented on physical distancing measures in Washington, and the impact it had on slowing COVID-19 transmission.
The New York Times recalled the story of the Washington COVID-19 outbreak and how genomic analysis helped track the virus, quoting Pavitra Roychoudhury and Trevor Bedford.
Louise Moncla explained why we need to expand COVID-19 tracing and testing abilities to interpret the spread that led to early deaths in California.
STAT News highlighted a Fred Hutch and AWS collaboration on a COVID-19 study called COVIDWatch
Trevor Bedford’s statements on when COVID-19 began circulating in the U.S. and Nextstrain findings are referenced.
Dr. Joshua Schiffer commented on a new COVID-19 patient registry to improve research efforts.
Dr. Joshua Schiffer is quoted on the use of hydroxychloroquine for COVID-19 treatment and the lack of understanding of its impact.
Dr. Elizabeth Halloran emphasized the difficulty in determining to number of COVID-19 cases due to lack of testing.
Trevor Bedford’s work is referenced as part of an analysis of how we study pandemics and disease.
Drs. Tom Lynch and Larry Corey recalled the start of the COVID-19 epidemic and discussed Fred Hutch’s efforts to track and control the virus along with other notable Seattle companies.
Dr. Elizabeth Halloran explained that COVID-19 serological tests have not yet been perfected, and some may give false results.
GeekWire covered a new Fred Hutch study, Covidwatch, focused on those most at risk to get COVID-19, to help us better understand characteristics of the virus.
Early results from the SCAN program, of which Fred Hutch is a partner, are discussed.
Trevor Bedford’s statements reinforcing COVID-19 was not in the U.S. last fall are referenced.
Dr. Tom Lynch commented on the hard work and early data from the SCAN COVID-19 testing program.
Trevor Bedford’s tweets explaining his test, trace, and isolate strategies for COVID-19 using digital and non-digital tools are discussed.
Dr. Elizabeth Halloran commented on the possibility of herd immunity to COVID-19, suggesting we have not reached that level of infection.
Trevor Bedford commented on how mutation rates may or may not impact a COVID-19 vaccine.
Dr. Elizabeth Halloran advised on the conditions necessary to lift COVID-19 lockdowns and keep the virus under control.
Trevor Bedford’s digital tracing endeavor, Nexttrace, is cited as one way to slow COVID-19.
Larry Corey provided context to a new study from Fred Hutch and UW suggesting Washington state has successfully lowered COVID-19 infections through physical distancing measures.
Trevor Bedford is listed as a COVID-19 expert, to help reduce misinformation about the virus.
PLoS Blogs delved into science communications, referencing Trevor Bedford’s use of twitter to explain COVID-19 research.
Trevor Bedford’s genomic analysis work to track COVID-19 from the initial outbreak in the U.S. is mentioned.
Trevor Bedford suggested even with lifted physical distancing measures, COVID-19 may not rebound as strongly as the public exercises more caution.
Fred Hutch Coaches vs. COVID fundraiser Tanner Swanson discussed why he was motivated to fundraise for Fred Hutch research.
KOMO covered Trevor Bedford’s latest tweets debunking beliefs that COVID-19 was circulating prior to January in Washington and California.
Trevor Bedford’s statements reinforcing the timeline of the U.S. COVID-19 outbreak are included, along with data from Nextstrain.
Dr. Elizabeth Halloran and Trevor Bedford’s recommendations to keep COVID-19 at bay and loosen physical distancing measures are discussed.
Jesse Bloom and Harmit Malik explained the process of a viral infection, referencing SARS-CoV-2 from first introduction into the body to the onset of the infection.
Allison Black, a genomic epidemiologist in the Bedford Lab, debunked sentiments that SARS-CoV-2 was circulating in the U.S. in fall 2019.
Trevor Bedford’s work on NextTrace, a digital COVID-19 tracing method, is highlighted.
Dr. Steve Pergam commented on the increased susceptibility for COVID-19 within cancer patients, and how oncologists should prepare.
Dr. Steve Pergam, along with other first responders in the Seattle area, published a piece on the COVID-19 pandemic and outbreaks in Washington.
Trevor Bedford’s latest tweets suggesting physical distancing measures have been effective in Washington state are cited.
Drs. Keith Jerome and Larry Corey explained work on blood tests for CoV-2 antibodies and the need for a vaccine.
Trevor Bedford reinforced that his genomic analysis suggested a January introduction of COVID-19 to the U.S.
Trevor Bedford’s analysis suggesting a mid-January start date for the COVID-19 outbreak in Washington state is referenced.
Trevor Bedford’s initial research suggesting community COVID-19 transmission in Washington is recalled.
Trevor Bedford’s early analysis that COVID-19 was circulating undetected in Washington State is referenced.
Trevor Bedford is referenced for his work and comments on fighting COVID-19.
Dr. Steve Pergam’s comments on how COVID-19 compares to the flu are included.
GeekWire covered Dr. Steve Pergam’s live COVID-19 Q&A, highlighting ways to stay safe but social.
Dr. Elizabeth Halloran answered questions about the outlook for COVID-19, and next steps to stop the pandemic.
GeekWire profiled Trevor Bedford’s new program NextTrace, that uses contact-tracing to stop COVID-19.
Dr. Gary Lyman and Dr. Michael Boeckh discussed patient care and safety during COVID-19, and the Cancer Care COVID-19 registry.
Undark mentioned Trevor Bedford’s use of twitter to comment on a preprint paper about COVID-19.
Trevor Bedford’s use of genetic data to link the COVID-19 patients in Washington is cited.
Dr. Larry Corey commented on the quick development of potential vaccines and vaccine trials for COVID-19.
Trevor Bedford’s proposed strategies for slowing and tracking COVID-19 spread are considered, along with others.
Wired reflected on Trevor Bedford’s analysis that by early March COVID-19 had already been circulating in Washington State for weeks.
Dr. Larry Corey explained how the Seattle scientific community is stepping up to tackle COVID-19.
Trevor Bedford’s analysis indicating COVID-19 community transmission had occurred in January is discussed.
The Washington Post discussed a report co-written by Trevor Bedford, outlining steps to guide states through the COVID-19 outbreak.
Trevor Bedford is included in a list of scientific resources on COVID-19.
Dr. Jesse Bloom discussed the logistics of developing and using a serological test for the virus causing COVID-19, to determine who has been exposed to the virus.
Dr. Kristin Anderson wrote about the researchers in Seattle who are working together to study and combat COVID-19, including Drs. Keith Jerome, Alex Greninger and Trevor Bedford.
Dr. Julie McElrath estimated when the COVID-19 outbreak will reach its peak and when we might see a lift on physical distancing measures.
Trevor Bedford explained how Nextstrain has evolved with open and rapid data sharing, allowing for real time tracking of COVID-19 mutations and spread.
Dr. Julie McElrath discussed potential COVID-19 vaccine options and programs.
Vox mentioned Trevor Bedford’s U.S. COVID-19 infection estimates and research on the spread of the virus.
Dr. Joshua Schiffer and Bryan Mayer discussed viral load variability in patients and what that could mean for COVID-19.
The Nextstrain project and Trevor Bedford’s analyses on COVID-19 are explained.
Trevor Bedford commented on the implications of COVID-19’s slow mutation rates, suggesting it will lead to immunity after exposure.
Trevor Bedford’s comments on the mutation patterns of COVID-19 and how that impacts vaccine production are cited.
Drs. Steve Pergam and Masumi Ueda gave expert advice on treating cancer patients during the COVID-19 pandemic.
Dr. Steve Pergam called for more scientific involvement in decisions around COVID-19 containment.
The new SCAN initiative is profiled, mentioning Fred Hutch as one of the founding partners.
Dr. Masumi Ueda explained how Fred Hutch’s clinical care partner Seattle Cancer Care Alliance approached COVID-19 prevention and identification in clinics and workspaces.
Trevor Bedford is quoted on ideas to tackle the COVID-19 pandemic through social distancing and extensive testing.
Trevor Bedford’s tweets on suggested strategies to curb the COVID-19 pandemic are quoted, specifically on the need for increased testing and social distancing.
Dr. Elizabeth Halloran reinforced the need for COVID-19 testing to control the pandemic.
Trevor Bedford and Dr. Elizabeth Halloran provided expertise for this interactive COVID-19 map, which overlays travel and migration data with epidemiological data.
The Atlantic described Trevor Bedford’s work in discovering COVID-19 had spread in Washington to his recommendations for slowing the pandemic.
Trevor Bedford commented on U.S. COVID-19 infection rates, providing estimates between 10,000 – 40,000.
Dr. Steve Pergam gave insight on the risk of cancer patients for COVID-19 infection.
Dr. Elizabeth Halloran provides context to COVID-19 transmission rates and spread.
Trevor Bedford and Jesse Bloom gave context to how they used genomic analysis of COVID-19 to track its spread.
Dr. Elizabeth Halloran explained community transmission and how it can lead to an epidemic in reference to COVID-19.
Trevor Bedford’s methods for stopping the COVID-19 outbreak are outlined, including isolating the infected, and having those who are recovered return to work.
Trevor Bedford commented on a new modeling report, suggesting how social distancing measures and testing can stop the COVID-19 pandemic.
WebMD discussed Dr. Elizabeth Halloran’s Science paper on COVID-19 modeling and preventative measures to limit transmission.
Trevor Bedford commented on the Ohio COVID-19 infection numbers, suggesting they are overestimated.
Dr. Steve Pergam provided crucial advice on social distancing and the role it plays in preventing COVID-19 spread.
Vox mentioned Trevor Bedford’s estimates that there are around 20,000 COVID-19 cases across the U.S. to date.
Dr. Elizabeth Halloran, an infectious disease expert, provided commentary on the need for widespread COVID-19 testing.
Dr. Elizabeth Halloran reinforced the importance of testing and social distancing to lower COVID-19 transmission.
Dr. Steve Pergam gave Healio in depth advice to cancer patients to protect themselves from COVID-19.
Dr. Keith Jerome’s COVID-19 test kit and the development of UW’s testing facilities are discussed.
Politico referenced Trevor Bedford’s estimate that there are between 10,000 – 40,000 U.S. COVID-19 cases.
Dr. Elizabeth Halloran stressed the importance of wide-spread testing to slow the spread of COVID-19.
Trevor Bedford’s commented on COVID-19 infection rate estimates across the U.S. are considered.
The Associated Press explored if reinfection is possible, referencing research on COVID-19 mutation rates from Fred Hutch.
Snopes referenced Fred Hutch research on mutation rates of COVID-19 in relation to the possibility of reinfection.
Trevor Bedford’s estimates of U.S. COVID-19 infection rates are mentioned in light of new outbreaks.
Dr. Steve Pergam is interviewed on COVID-19 and the risk to immunocompromised people.
Dr. Steve Pergam, an infectious disease expert, provided commentary on social distancing in light of COVID-19.
Trevor Bedford’s research suggesting most new COVID-19 cases are due to community transmission rather than travel is highlighted.
Trevor Bedford’s tweets on transmission chains leading to COVID-19 outbreaks across the U.S. are mentioned.
Betz Halloran commented on the power of data science and modeling to track COVID-19 and other viruses.
A modeling study from Fred Hutch is cited on results suggesting Seattle two weeks ago was approximately in the position of Wuhan, China, on Jan. 1.
Dr. Steve Pergam provided expert commentary for cancer patients in light of COVID-19 and increased risk.
Results from a preliminary paper indicating that social distancing is effective at lowering disease spread by Trevor Bedford and colleagues is mentioned.
David Fredricks commented on outcomes of a large, international study showing that the microbiome predicts transplant success.
Open data sharing and the use of Nextstrain by Trevor Bedford and colleagues to track COVID-19 is discussed.
Trevor Bedford’s discovery of community transmission of COVID-19 in Washington is referenced.
Trevor Bedford is included in a list of COVID-19 experts.
Vox referenced Trevor Bedford’s analysis on the impact of travel bans to prevent COVID-19 spread.
Results from a preliminary paper indicating that social distancing is effective at lowering disease spread by Trevor Bedford and colleagues is mentioned.
Dr. Elizabeth Halloran discussed her Science study showing how travel bans slowed but did not stop the spread of COVID-19.
A study by Trevor Bedford and colleagues predicting infection rates is referenced in light of new social distancing measures.
Trevor Bedford’s analysis on infection rates and the efficacy of travel bans to lower COVID-19 transmission is discussed.
Trevor Bedford explained his analysis of the transmission pathway of COVID-19 throughout Washington, likely beginning with one person.
Infectious disease expert Betz Halloran provided global infection rate estimates based on her research.
Trevor Bedford is referenced for his research suggesting a larger outbreak in Washington than testing has reflected.
Trevor Bedford’s research with Seattle Flu Study is referenced as support for new social distancing measures.
Vanity Fair profiled Trevor Bedford and Nextstrain collaborators, referencing tracking COVID-19, genomic analysis and transmission rates.
Dr. Steve Pergam comments on COVID-19 risk for cancer patients.
Massive Science delves into how COVID-19 spread without detection, referencing Trevor Bedford’s detailed genetic analysis of community transmission.
Dr. Steve Pergam is quoted on his advice for cancer patients in light of increased risk for COVID-19.
GeekWire discussed social distancing in light of Trevor Bedford’s COVID-19 transmission predictions.
Trevor Bedford is quoted among other Nextstrain collaborators on their COVID-19 analysis, in light of Italy's outbreak.
Trevor Bedford’s genetic analysis on the spread of COVID-19 into Italy and the spread across Washington State is considered.
Bloomberg followed the Washington COVID-19 outbreak, including Trevor Bedford’s discovery of community transmission and subsequent genetic analysis of the spread.
Fred Hutch and Trevor Bedford’s modeling results suggesting undetected COVID-19 are cited in a commentary about COVID-19 spread.
Fred Hutch is mentioned as one of the institutions supporting Seattle Flu Study.
Trevor Bedford is quoted on his research on missed transmission pathways of COVID-19.
Trevor Bedford’s data indicating untracked COVID-19 spread in Washington State is referenced.
Biostatistician Elizabeth Halloran’s research on the role of travel restrictions in delaying COVID-19 spread is discussed.
Fred Hutch research on COVID-19 community transmission rates in Kirkland, Washington is mentioned.
The Cancer Letter includes Fred Hutch’s remote work policy in a list of updates related to COVID-19.
FierceBiotech profiled Fred Hutch for COVID-19 remote work policies and for Trevor Bedford’s COVID-19 research.
Computational biologist Trevor Bedford explained how researchers are using Nextstrain and genetic analysis techniques to track COVID-19 in real time.
Gates Foundation funding of COVID-19 research, including Fred Hutch and Seattle Flu Study, is mentioned.
Computational biologist Trevor Bedford discussed how he has been using Nextstrain to understand COVID-19 genetics and spread.
Seattle Flu Study is profiled, delving into Drs. Keith Jerome, Helen Chu and Trevor Bedford’s research on COVID19 genetic analysis and vaccine development.
Trevor Bedford’s research using the Nextstrain platform is explored, specifically its role in real time tracking of COVID-19.
Trevor Bedford's research suggesting under detection of COVID-19 cases in Washington State is mentioned.
Virologist Dr. Keith Jerome’s COVID-19 testing kit is discussed, along with Trevor Bedford’s computational analysis of COVID-19 spread.
Fred Hutch’s work from home policy is mentioned, among other local organizations, as a response to the COVID-19 outbreak in Washington State.
Trevor Bedford explains how a lack of testing allowed COVID-19 to spread undetected in Washington State.
Trevor Bedford’s work on the spread and genetic variation of COVID-19 from China to the US is discussed.
A columnist referenced computational biologist Trevor Bedford and his blog content on COVID-19 projected spread and recommendations.
Fred Hutch and computational biologist Trevor Bedford are referenced on the COVID-19 outbreak and preventative measures cities are taking to slow the spread of the virus.
Dr. Keith Jerome, a virologist, provided commentary on his new COVID-19 testing kit at UW Medicine.
The rapid data sharing involved in Trevor Bedford’s work is discussed as an example of open science.
Computational biologist Trevor Bedford explained his analysis on COVID-19 spread and provided recommendations for the greater Seattle area.
Infectious disease expert Dr. Steve Pergam comments on what people with HIV need to know about COVID-19
Trevor Bedford, a computational biologist, is quoted on his COVID-19 genetic analysis.
Computational biologist Trevor Bedford and his research on the Washington COVID-19 outbreak is discussed.
Trevor Bedford, a computational biologist, provided expert commentary on the infection rates and genetic analysis of COVID-19.
Dr. Steve Pergam, an infectious disease expert, provided insight on COVID-19 risk for cancer patients.
Computational biologist Trevor Bedford discussed his analysis providing COVID-19 infection estimates for Washington state
Trevor Bedford, a computational biologist, is quoted on the COVID-19 spread and genetic analysis.
Computational biologist Trevor Bedford is quoted on COVID-19 transmission in Seattle.
Computational biologist Trevor Bedford is quoted on the COVID-19 outbreak in Seattle.
Trevor Bedford, a computational biologist, is mentioned in reference to COVID-19 genetic analysis and spread in Washington.
Computational biologist Trevor Bedford and Fred Hutch are mentioned in reference to the COVID-19 outbreak and genetic analysis.
Trevor Bedford, a computational biologist, provided expert commentary on the origins of COVID-19.
Elizabeth Halloran, an infectious disease expert, discussed modeling and projections for COVID-19’s spread.
Trevor Bedford, a computational biologist, shared his thoughts on how open data sharing has aided real-time tracking of COVID-19.
Trevor Bedford, a computational biologist, discussed COVID-19 and his research on the virus’ genome.
Computational biologist Trevor Bedford’s research on COVID-19 is mentioned in reference to a patient in Everett, Washington.
Computational biologist Trevor Bedford discussed projections for the spread of COVID-19.
Trevor Bedford, a computational biologist, provided expert commentary on COVID-19.
Computational biologist Trevor Bedford discussed COVID-19.
Trevor Bedford, a computational biologist, discussed his analysis of COVID-19 genomes.
Computational biologist Trevor Bedford provided expert commentary on COVID-19.
Dr. Raphael Gottardo discussed how machine learning can help his work in immunotherapy research.
Forbes detailed the current status of HIV trials, including those conducted by the HIV Vaccine Trials Network, which is headquartered at Fred Hutch.
Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.
Dr. David Fredricks, a microbiome researcher, provided expert commentary on vaginal microbiota transplantation.
FierceBiotech featured a Fred Hutch study suggesting cross-subtype immune response against HIV in South Africa.
FierceBiotech featured a Fred Hutch study suggesting cross-subtype immune response against HIV in South Africa.
American Journal of Managed Care featured Dr. Tom Uldrick’s recent study showing that pembrolizumab is safe in cancer patients with HIV.
Reader’s Digest covered Dr. Justin Taylor’s recent study in Science Immunology on B cell engineering.
Science covered a B cell engineering study led by Dr. Justin Taylor.
GeekWire covered Fred Hutch Dr. Justin Taylor’s recent work using gene editing to protect against HIV and other viruses.
Fred Hutch virologist Dr. Keith Jerome provided expert commentary about the second person who reportedly has been cured of HIV.
Fred Hutch virologist Dr. Keith Jerome provided context around news of the second person who reportedly has been cured of HIV. He commented, “Now there’s not one, but two people that others living with HIV can look toward for encouragement.”
This article notes research led by Dr. Justin Taylor using CRISPR, a gene-editing tool, to fight viruses when vaccines can’t. Taylor explained how his team has been investigating CRISPR as a tool to edit B cells in mice that could synthesize antibodies against respiratory syncytial virus (RSV).
Fred Hutch Dr. Trevor Bedford comments on the value of the Seattle Flu Study.
Fred Hutch researcher Drs. Keith Jerome, Hans-Peter Kiem and Michael Louella, who coordinates the research group’s Community Advisory Board, provide expert comments on the importance of community engagement in HIV research.
This story features the Seattle Flu Study, a new project from the Brotman Baty Institute which was co-founded by Seattle Children’s, UW Med and Fred Hutch. The study will look at 10,000 swabs to better understand how the flu spreads and how to prevent it. Fred Hutch’s Dr. Trevor Bedford is the lead data scientist for the study.
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
Fred Hutch researcher Dr. Steve Pergam is featured as GeekWire’s ‘Geek of the Week’. Dr. Pergam is an associate member of the Vaccine and Infectious Disease Division at Fred Hutch.
Fred Hutch researcher Dr. Steve Pergam comments on cannabis use among cancer patients.
This segment, which aired on the eve of World AIDS Day, covers local and global HIV vaccine trials led by Fred Hutch. It includes interviews with Drs. Janine Maenza, Larry Corey and an HIV study vaccine participant.
This article features a recent study by Fred Hutch Drs. Dan Reeves and Josh Schiffer that shows that a majority of the HIV-infected cells that persist in HIV-infected individuals even during suppressive antiretroviral therapy (ART) originate from cellular proliferation, not viral replication.
Dr. Trevor Bedford comments on a study that suggests that people living in smaller cities are more likely to face an intense outbreaks of seasonal flu during flu season.
KOMO featured Kristen Cohen and Ro Yoon in a story about a new HIV vaccine trial for which Fred Hutch is one of two sites.
GeekWire covered the launch of a new HIV vaccine trial for which Fred Hutch will serve as one of two sites.
Dr. Keith Jerome, a virologist at Fred Hutch, co-authored a 2016 study about gene editing in herpes-infected mice. “His is the first study to show that gene-editing technology can reach the latent virus in a nerve cell, and the first to use that technology to damage some of the virus’ DNA,” according to a Smithsonian.com article on this and other efforts to combat the virus in humans.
Coverage of Open Science Prize, awarded to Drs. Trevor Bedford and Richard Neher
Article explains a new genetic tool, Nexstrain, for which creators Drs. Trevor Bedford and Richard Neher were awarded the inaugural Open Science Prize by the National Institutes of Health, Wellcome Trust and Howard Hughes Medical Institute
Profile of Dr. Larry Corey and his research on how immunotherapy could be used to attack HIV and other viruses
Article about a $2.6 million grant from Gilead Sciences to Dr. Larry Corey for HIV-cure research
A study co-authored by Dr. Jim Kublin and Center for Infectious Disease Research investigator Dr. Stefan Kappe found a promising approach to developing a malaria vaccine
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising new approach to developing a malaria vaccine
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
A study co-authored by Dr. Jim Kublin and researchers at the Center for Infectious Disease Research found a promising approach to developing a malaria vaccine
Quotes Elizabeth Brown from the vaccine and infectious disease division on her study on women using vaginal rings to prevent HIV infection. Brown's research follows the larger ASPIRE study that tested the monthly ring
Quotes Elizabeth Brown from the vaccine and infectious disease division on her study on women using vaginal rings to prevent HIV infection. Brown's research follows the larger ASPIRE study that tested the monthly ring
Editorial by Fred Hutch HIV vaccine researcher and Director Emeritus Dr. Larry Corey and Nobel laureate Dr. David Baltimore of the California Institute of Technology
Article about the next frontier in cancer immunotherapy quotes Dr. Martin "Mac" Cheever, a cancer immunologist at Fred Hutch
Article about a new blood test to predict whether latent tuberculosis will develop into active TB mentions that a related TB vaccine clinical trial in Cape Town, South Africa, was designed by biostatisticians at Fred Hutch